NYSEARCA:LABU Direxion Daily S&P Biotech Bull 3X ETF (LABU) Price, Holdings, & News $195.22 -19.61 (-9.13%) Closing price 04:10 PM EasternExtended Trading$195.38 +0.16 (+0.08%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHoldingsNews and TrendsOwnershipRatingsShort Interest About Direxion Daily S&P Biotech Bull 3X ETF (NYSEARCA:LABU) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get LABU alerts:Sign Up Key Stats Today's Range$193.36▼$218.5050-Day Range$195.22▼$293.0752-Week Range$130.11▼$341.93Volume404,794 shsAverage Volume528,246 shsMarket Capitalization$482.19 millionAssets Under Management$539.64 millionDividend Yield0.47%Net Expense Ratio0.96%Aggregate RatingModerate Buy ETF Overview The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion. Read More Direxion Daily S&P Biotech Bull 3X ETF ExpensesTypeLABUHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.75%0.55%0.57%0.50%0.53%Other Expenses0.21%0.52%0.53%0.60%0.54%Total Expense0.96%0.76%0.75%0.75%0.73%Fee Waiver0.00%-0.85%-0.67%-0.76%-0.67%Net Expense0.96%0.58%0.63%0.57%0.60% Receive LABU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Direxion Daily S&P Biotech Bull 3X ETF and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. LABU ETF News HeadlinesWhy $55 Million Flowed Into a Triple-Leveraged Biotech ETF Worth Less Than $600 MillionOctober 20, 2026 | 247wallst.com(LABU) Direxion Daily S&P Biotech Bull 3X SharesSeptember 26, 2026 | sa.investing.comYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. They don't know the rules. They don't know what to avoid. And they hand their account to Wall Street on a silver platter. Normally $29.97. Free today.November 16 at 1:00 AM | Profits Run (Ad)LABU Could Rip Higher if Biotech Finally Gets Its Long-Awaited BreakoutApril 27, 2026 | 247wallst.comEqual-Weight ETFs Are the Play for Small-Cap Drug Development. Here's How to Position NowApril 23, 2026 | 247wallst.comSPXL: Replacing SPY With 3x Leverage Proven To Yield Positive Long-Term ResultsMarch 25, 2026 | seekingalpha.comSee More Headlines LABU ETF - Frequently Asked Questions How have LABU shares performed this year? Direxion Daily S&P Biotech Bull 3X ETF's stock was trading at $159.39 at the beginning of the year. Since then, LABU shares have increased by 22.5% and is now trading at $195.22. When did Direxion Daily S&P Biotech Bull 3X ETF's stock split? Direxion Daily S&P Biotech Bull 3X ETF's stock reverse split on the morning of Monday, December 4th 2023.The 1-20 reverse split was announced on Monday, December 4th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, December 4th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. Who are Direxion Daily S&P Biotech Bull 3X ETF's major shareholders? Direxion Daily S&P Biotech Bull 3X ETF's top institutional investors include McGuire Investment Group LLC (0.19%), SBI Securities Co. Ltd. (0.04%), Halbert Hargrove Global Advisors LLC (0.04%) and HighTower Advisors LLC (0.04%). How do I buy shares of Direxion Daily S&P Biotech Bull 3X ETF? Shares of LABU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Direxion Daily S&P Biotech Bull 3X ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that Direxion Daily S&P Biotech Bull 3X ETF investors own include NVIDIA (NVDA), Direxion Daily Semiconductors Bull 3X ETF (SOXL), Tesla (TSLA), Micron Technology (MU), ProShares UltraPro QQQ (TQQQ), Alibaba Group (BABA) and Advanced Micro Devices (AMD). Fund Details IssuerDirexion Fund NameDirexion Daily S&P Biotech Bull 3X ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:LABU Inception Date5/28/2015 Fund ManagerPaul Brigandi, Tony Ng WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkS&P Biotechnology Select Industry Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Constituents189 Fund Statistics Assets Under Management$539.64 million Average Daily Volume$362.79 thousand Discount/Premium0.47% Leveraged3.00 Administrator, Advisor and Custodian AdministratorU.S. Bancorp Fund Services, LLC AdvisorRafferty Asset Management, LLC CustodianThe Bank of New York Mellon Corporation DistributorForeside Fund Services, LLC Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerVirtu Financial Options OptionableOptionable Options Volume3,430 Put Options1,790 Call Options1,640 Short Interest387,260 shs Miscellaneous Outstanding Shares2,470,000Beta2.53 Creation Unit50,000 Creation Fee$250.00 7 Blue-Chip Stocks to Add To Your Forever PortfolioA strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership. This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.Get This Free Report Top 10 LABU HoldingsSPSIBI SWAP ASSET LEGHolding Weight: 63.15%SPSIBI SWAP ASSET LEGHolding Weight: 52.19%SPSIBI SWAP ASSET LEGHolding Weight: 47.53%SPSIBI SWAP ASSET LEGHolding Weight: 32.00%SPSIBI SWAP ASSET LEGHolding Weight: 21.51%GOLDMAN FINL SQ TRSRY INST 506Holding Weight: 16.84%SPSIBI SWAP ASSET LEGHolding Weight: 16.22%DREYFUS GOVT CASH MAN INSHolding Weight: 13.86%SPSIBI SWAP ASSET LEGHolding Weight: 2.82%Moderna (NASDAQ:MRNA)Holding Weight: 1.85%Full Holdings DetailsLABU Sector ExposureLABU Industry Exposure This page (NYSEARCA:LABU) was last updated on 11/16/2026 by MarketBeat.com Staff. From Our PartnersA $247 tool for $7Bill Poulos is offering his $247 Instant Scanner for $7 in the Black Friday sale. It's one payment for a full ...Profits Run | SponsoredWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...Porter & Company | SponsoredYour Copy is on Hold (Claim it now)James Altucher, who called NVIDIA in 2008 and SpaceX years before a single share traded, has a new report on E...Paradigm Press | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredSmall-Cap SMX is Taking its Technology into Multiple Trillion-Dollar Industries!SMX (NASDAQ: SMX) uses proprietary molecular-marking technology and a Digital Material Passport platform to gi...Smallcaps Daily | SponsoredThis Tech Could Be Bigger Than Apple, Amazon, and Microsoft CombinedA breakthrough technology backed by Elon Musk, Sam Altman and Jensen Huang could one day be worth more than Ap...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Direxion Daily S&P Biotech Bull 3X ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Direxion Daily S&P Biotech Bull 3X ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.